|
|
Volumn 29, Issue SUPPL. 2, 1996, Pages 83-95
|
|
The development of Casodex (Bicalutamide): Preclinical studies
a
|
|
Author keywords
Androgen antagonists; Antiandrogens; Bicalutamide; Casodex ; Drug treatment; Preclinical studies; Prostate cancer
|
|
Indexed keywords
ANDROGEN RECEPTOR;
ANTIANDROGEN;
BICALUTAMIDE;
FLUTAMIDE;
GOSERELIN;
HYDROXYFLUTAMIDE;
LUTEINIZING HORMONE;
TESTOSTERONE;
ANIMAL CELL;
ANIMAL EXPERIMENT;
ANIMAL MODEL;
BLOOD BRAIN BARRIER;
BREAST CANCER;
CANCER CELL CULTURE;
CASTRATION;
CELL GROWTH;
CONFERENCE PAPER;
CONTROLLED STUDY;
DOG;
DRUG HALF LIFE;
DRUG POTENCY;
DRUG RECEPTOR BINDING;
EPIDIDYMIS;
GENE EXPRESSION;
GROWTH INHIBITION;
LUTEINIZING HORMONE BLOOD LEVEL;
MALE;
MONKEY;
NONHUMAN;
NUCLEAR MAGNETIC RESONANCE IMAGING;
PRIORITY JOURNAL;
PROSTATE CANCER;
RAT;
TESTOSTERONE BLOOD LEVEL;
|
|
EID: 0030009598
PISSN: 03022838
EISSN: None
Source Type: Journal
DOI: 10.1159/000473846 Document Type: Conference Paper |
|
Times cited : (77)
|
|
References (0)
|
